b73a0fc4-358c-4093-bb84-3a2b35ff31a52026-07-22T07:41:00.000Z2026-09-30T23:59:00.000ZBASELINE10982A25732026N2026-07-22T07:40:00.000ZWIIFQSVXXIVBO E 0009990607S10640E999WIIF202607220741202609302359D-VOLMET LIMITED TRIAL IN PROGRESS. ACFT MAY REQUEST D-VOLMET FOR WIII. OPERATORS ARE REQUESTED TO REPORT ANY D-VOLMET ISSUES ENCOUNTERED DURING THE TRIALOTHER:ICAOA2573/26 NOTAMN Q) WIIF/QSVXX/IV/BO /E /000/999/0607S10640E999 A) WIIF B) 2607220741 C) 2609302359 E) D-VOLMET LIMITED TRIAL IN PROGRESS. ACFT MAY REQUEST D-VOLMET FOR WIII. OPERATORS ARE REQUESTED TO REPORT ANY D-VOLMET ISSUES ENCOUNTERED DURING THE TRIALINTLWRRRYNYXJAKARTA/PABELOKANWRRRYNYXWIIF/QSVXX/IV/BO /E /000/999/0607S10640E9992026-07-22T07:41:00.000ZWIIF952fb95b-f4f2-4e21-b7ff-68fb94077be52026-07-22T07:40:00.000ZSNAPSHOTWIIFJAKARTA/PABELOKANWIIF-6.116667 106.666667